Building proteins to counteract cancer

November 11, 2014 by Joe Kullman, Arizona State University
Building proteins to counteract cancer
Karmella Haynes (left) is leading research to explore the capability of genetically engineered proteins to reactivate tumor suppressors inside body cells to prevent the onset of cancer, or arrest its development. Credit: Jessica Hochreiter/ASU

Karmella Haynes wants to help the body fight cancer by designing proteins to stop the disease.

Haynes, a synthetic biologist at Arizona State University, is leading research to explore the capability of genetically engineered proteins to reactivate tumor suppressors inside body cells to prevent the onset of , or arrest its development.

"We can make and reprogram them to turn on natural tumor suppressors in cells that have been de-activated," said Haynes, an assistant professor in the School of Biological and Health Systems Engineering, one of ASU's Ira A. Fulton Schools of Engineering.

Cancer can set in when certain genes in the nucleus of cells lose their ability to restrain tumor development. That happens when chromatin – DNA and proteins that are folded together in chromosomes – becomes overactive. Cancer causes too many folding proteins to be produced – the tumor-restraining genes are folded too much, making these important genes lose their ability to function properly.

"We have the ability to build new synthetic proteins by borrowing pieces of the natural DNA-folding proteins. The new synthetic proteins are designed to counteract cancer-associated chromatin folding," Haynes explained.

Supported by a grant from National Cancer Institute through the National Institutes of Health (NIH), she is working on a technique for effectively introducing the engineered proteins into chromatin structures.

The new proteins would be programmed to attach to genes in a manner that should restore the tumor-suppressing function "and start killing ," she said.

Explore further: Synthetic lethality offers a new approach to kill tumor cells

Related Stories

Synthetic lethality offers a new approach to kill tumor cells

October 31, 2014
The scientific community has made significant strides in recent years in identifying important genetic contributors to malignancy and developing therapeutic agents that target altered genes and proteins. A recent approach ...

Chinese herbal extract may help kill off pancreatic cancer cells

July 1, 2014
A diagnosis of pancreatic cancer—the fourth most common cause of cancer death in the U.S.—can be devastating. Due in part to aggressive cell replication and tumor growth, pancreatic cancer progresses quickly and has a ...

A new target for diabetes treatment

November 25, 2013
In her synthetic biology lab, Karmella Haynes focuses much of her effort on developing better ways of exploring how human body cells work – or don't work like they should. She'll be applying her expertise in that area to ...

Cancer exosome 'micro factories' aid in cancer progression

October 23, 2014
Exosomes, tiny, virus-sized particles released by cancer cells, can bioengineer micro-RNA (miRNA) molecules resulting in tumor growth. They do so with the help of proteins, such as one named Dicer. New research from The University ...

New regions of genetic material are involved in the development of colon cancer

July 23, 2014
Most research on human cancer genes have been focused on the regions of the coding genome (exons) that are to be translated in the form of amino acids thus proteins. But just before each gene, there is a regulatory region ...

Recommended for you

Fusion hybrids: A newly discovered population of tumor cells

September 24, 2018
In a recent study published in Science Advances, Charles E. Gast and co-workers detail the spontaneous process of cancer cell fusion with white blood cells to produce heterogenous hybrid clones in multiple biological systems, ...

Cancer cells evade immunotherapy by hiding telltale marker, suggesting how to stop relapse

September 24, 2018
Harnessing the immune system to treat cancer shows great promise in some patients, but for many, the response does not last long-term. In an effort to find out why, Fred Hutchinson Cancer Research Center scientists are using ...

In zebrafish, a way to find new cancer therapies, targeting tumor modulators

September 21, 2018
The lab of Leonard Zon, MD, at Boston Children's Hospital has long been interested in making blood stem cells in quantity for therapeutic purposes. Looking for a way to test for their presence in zebrafish, their go-to research ...

What can salad dressing tell us about cancer? Think oil and vinegar

September 20, 2018
Researchers led by St. Jude Children's Research Hospital scientists have identified another way the process that causes oil to form droplets in water may contribute to solid tumors, such as prostate and breast cancer. The ...

Novel biomarker found in ovarian cancer patients can predict response to therapy

September 20, 2018
Despite months of aggressive treatment involving surgery and chemotherapy, about 85 percent of women with high-grade wide-spread ovarian cancer will have a recurrence of their disease. This leads to further treatment, but ...

Testing fluorescent tracers used to help surgeons determine edges of breast cancer tumors

September 20, 2018
A team of researchers with members from institutions in The Netherlands and China has conducted a test of fluorescent tracers meant to aid surgeons performing tumor removal in breast cancer patients. In their paper published ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.